PL366975A1 - Pharmaceutical composition containing oxalyplatinum as well as method for its manufacture - Google Patents

Pharmaceutical composition containing oxalyplatinum as well as method for its manufacture

Info

Publication number
PL366975A1
PL366975A1 PL04366975A PL36697504A PL366975A1 PL 366975 A1 PL366975 A1 PL 366975A1 PL 04366975 A PL04366975 A PL 04366975A PL 36697504 A PL36697504 A PL 36697504A PL 366975 A1 PL366975 A1 PL 366975A1
Authority
PL
Poland
Prior art keywords
oxalyplatinum
manufacture
well
pharmaceutical composition
composition containing
Prior art date
Application number
PL04366975A
Other languages
Polish (pl)
Inventor
Borek Zaludek
Jan Boleslav
Vladimir Kysilka
Jiri Verner
Hana Brzobohata
Bozena Matejkova
Milan Kakrda
Original Assignee
Pliva-Lachema A.S.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pliva-Lachema A.S. filed Critical Pliva-Lachema A.S.
Publication of PL366975A1 publication Critical patent/PL366975A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/555Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
PL04366975A 2003-09-02 2004-04-05 Pharmaceutical composition containing oxalyplatinum as well as method for its manufacture PL366975A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CZ20032367A CZ300795B6 (en) 2003-09-02 2003-09-02 Pharmaceutical composition and process for its preparation

Publications (1)

Publication Number Publication Date
PL366975A1 true PL366975A1 (en) 2005-03-07

Family

ID=34256928

Family Applications (1)

Application Number Title Priority Date Filing Date
PL04366975A PL366975A1 (en) 2003-09-02 2004-04-05 Pharmaceutical composition containing oxalyplatinum as well as method for its manufacture

Country Status (6)

Country Link
EP (1) EP1663106A2 (en)
CA (1) CA2537610A1 (en)
CZ (1) CZ300795B6 (en)
PL (1) PL366975A1 (en)
RU (1) RU2329052C2 (en)
WO (1) WO2005020876A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2675788A1 (en) * 2007-01-22 2008-07-31 Pliva - Lachema A.S. Oxaliplatin pharmaceutical composition with alcoholic sugar-based buffer
CZ300664B6 (en) * 2007-01-22 2009-07-15 Pliva-Lachema A. S. Sterile liquid pharmaceutical composition and process for preparing thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994012193A1 (en) * 1992-11-24 1994-06-09 Debiopharm S.A. Cisplatinum/oxaliplatinum combination
GB9804013D0 (en) * 1998-02-25 1998-04-22 Sanofi Sa Formulations
DE60005376T2 (en) * 1999-08-30 2004-07-01 Debiopharm S.A. STABILIZED PHARMACEUTICAL PREPARATION TO BE USED WITH OXALIPLATINE-BASED PARENTERAL AND METHOD FOR THE PRODUCTION THEREOF
DE10314377A1 (en) * 2003-03-28 2004-10-07 Stada Arzneimittel Ag Pharmaceutical composition useful for tumor therapy comprises water, oxaliplatin and an acid other than oxalic acid

Also Published As

Publication number Publication date
RU2329052C2 (en) 2008-07-20
CA2537610A1 (en) 2005-03-10
RU2006110563A (en) 2006-08-10
EP1663106A2 (en) 2006-06-07
CZ300795B6 (en) 2009-08-12
WO2005020876A3 (en) 2005-06-09
WO2005020876A2 (en) 2005-03-10
CZ20032367A3 (en) 2005-04-13

Similar Documents

Publication Publication Date Title
TWI350751B (en) Pharmaceutical compositions for treating diabetes
GB0320382D0 (en) Pharmaceutical compositions
GB0327723D0 (en) Pharmaceutical compositions
IL175655A0 (en) Method for making pharmaceutical multiparticulates
HU0301154D0 (en) Pharmaceutical composition
ZA200605080B (en) Pharmaceutical compositions
GB0300427D0 (en) Pharmaceutical composition
GB0300531D0 (en) Pharmaceutical compositions
HK1084670A1 (en) Pharmaceutical compositions comprising cabbinochreme type compounds
EP1648411A4 (en) Pharmaceutical compositions
GB0307866D0 (en) Pharmaceutical composition
EP1699458A4 (en) Pharmaceutical composition
GB0329232D0 (en) Pharmaceutical composition
GB0317663D0 (en) Pharmaceutical composition
PL366653A1 (en) Method for manufacture of polyorganooxosilane compositions
AU2003231920A8 (en) Antiinfectve compounds, process for their preparation and pharmaceutical compositions containing them
PT1603550E (en) Pharmaceutical composition comprising 5-methyl-2-2`-(chloro-6`-fluoroanilino)phenylacetic acid
GB0300885D0 (en) Pharmaceutical composition
GB0306933D0 (en) Pharmaceutical composition
IL189177A0 (en) Process for producing carcosporamide and pharmaceutical compositions containing cercosporamide
PL366975A1 (en) Pharmaceutical composition containing oxalyplatinum as well as method for its manufacture
EP1659167A4 (en) Process for producing monoglyceride-containing composition
GB0307869D0 (en) Pharmaceutical composition
IL174589A0 (en) Pharmaceutical compositions containing tetrahydrobiopterin
GB0305579D0 (en) Pharmaceutical compositions

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)